Elekta is a global leader in medical technology, developing advanced solutions for cancer treatment. Focusing on precise radiotherapy, radiosurgery, and brachytherapy, Elekta empowers clinicians worldwide to treat cancer patients more effectively. The company's innovative oncology technology significantly enhances patient care.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Elekta is scheduled to report its next quarterly earnings on 11/25/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Elekta last reported quarterly earnings on 8/27/2026 (Q2 2026). Earnings per share (EPS) came in at 0.69 SEK.
Elekta has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.